Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging

PurposeTo compare the diagnostic performance of transperineal targeted biopsy (TB) or systematic biopsy (SB) alone based on combined TB+SB and radical prostatectomy (RP) specimen for detecting prostate cancer (PCa) according to the prostate imaging reporting and data system (PI-RADS) score. Material...

Full description

Bibliographic Details
Main Authors: Tae Il Noh, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Sung Gu Kang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1142022/full
_version_ 1797860868478730240
author Tae Il Noh
Ji Sung Shim
Seok Ho Kang
Jun Cheon
Sung Gu Kang
author_facet Tae Il Noh
Ji Sung Shim
Seok Ho Kang
Jun Cheon
Sung Gu Kang
author_sort Tae Il Noh
collection DOAJ
description PurposeTo compare the diagnostic performance of transperineal targeted biopsy (TB) or systematic biopsy (SB) alone based on combined TB+SB and radical prostatectomy (RP) specimen for detecting prostate cancer (PCa) according to the prostate imaging reporting and data system (PI-RADS) score. Materials and methodsThis study included 1077 men who underwent transperineal bi-parametric (bp) magnetic resonance imaging (MRI)–ultrasound (US) fusion TB+SB (bpMRI-US FTSB) between April 2019 and March 2022. To compare the performance of each modality (TB, SB, and combined TB+SB) with the RP specimen (as the standard) for detecting PCa and clinically significant PCa (csPCa), receiver operating characteristic (ROC) curves were plotted.ResultsPCa was detected in 581 of 1077 men (53.9%) using bpMRI-US FTSB. CsPCa was detected in 383 of 1077 men (35.6%), 17 of 285 (6.0%) with PI-RADS 0 to 2, 35 of 277 (12.6%) with PI-RADS 3, 134 of 274 (48.9%) with PI-RADS 4, and 197 of 241 (81.7%) with PI-RADS 5, respectively. The additional diagnostic value of TB vs. SB compared to combined TB+SB for diagnosing csPCa were 4.3% vs. 3.2% (p=0.844), 20.4% vs 5.1% (p<0.001), and 20.3% vs. 0.7% (p<0.001) with PI-RADS 3, 4, and 5, respectively. TB alone showed no significant difference in diagnostic performance for csPCa with combined TB+SB based on RP specimens in patients with PI-RADS 5 (p=0.732).ConclusionA need for addition of SB to TB in patients with PI-RADS 3 and 4 lesions, however, TB alone may be performed without affecting the management of patients with PI-RADS 5.
first_indexed 2024-04-09T21:52:55Z
format Article
id doaj.art-34652d3d31604059b692ca622a683bd1
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T21:52:55Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-34652d3d31604059b692ca622a683bd12023-03-24T11:00:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11420221142022Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imagingTae Il NohJi Sung ShimSeok Ho KangJun CheonSung Gu KangPurposeTo compare the diagnostic performance of transperineal targeted biopsy (TB) or systematic biopsy (SB) alone based on combined TB+SB and radical prostatectomy (RP) specimen for detecting prostate cancer (PCa) according to the prostate imaging reporting and data system (PI-RADS) score. Materials and methodsThis study included 1077 men who underwent transperineal bi-parametric (bp) magnetic resonance imaging (MRI)–ultrasound (US) fusion TB+SB (bpMRI-US FTSB) between April 2019 and March 2022. To compare the performance of each modality (TB, SB, and combined TB+SB) with the RP specimen (as the standard) for detecting PCa and clinically significant PCa (csPCa), receiver operating characteristic (ROC) curves were plotted.ResultsPCa was detected in 581 of 1077 men (53.9%) using bpMRI-US FTSB. CsPCa was detected in 383 of 1077 men (35.6%), 17 of 285 (6.0%) with PI-RADS 0 to 2, 35 of 277 (12.6%) with PI-RADS 3, 134 of 274 (48.9%) with PI-RADS 4, and 197 of 241 (81.7%) with PI-RADS 5, respectively. The additional diagnostic value of TB vs. SB compared to combined TB+SB for diagnosing csPCa were 4.3% vs. 3.2% (p=0.844), 20.4% vs 5.1% (p<0.001), and 20.3% vs. 0.7% (p<0.001) with PI-RADS 3, 4, and 5, respectively. TB alone showed no significant difference in diagnostic performance for csPCa with combined TB+SB based on RP specimens in patients with PI-RADS 5 (p=0.732).ConclusionA need for addition of SB to TB in patients with PI-RADS 3 and 4 lesions, however, TB alone may be performed without affecting the management of patients with PI-RADS 5.https://www.frontiersin.org/articles/10.3389/fonc.2023.1142022/fullmagnetic resonance imagingtransperineal biopsyprostate cancerPI-RADStarget biopsy
spellingShingle Tae Il Noh
Ji Sung Shim
Seok Ho Kang
Jun Cheon
Sung Gu Kang
Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
Frontiers in Oncology
magnetic resonance imaging
transperineal biopsy
prostate cancer
PI-RADS
target biopsy
title Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
title_full Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
title_fullStr Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
title_full_unstemmed Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
title_short Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
title_sort diagnostic performance of transperineal prostate targeted biopsy alone according to the pi rads score based on bi parametric magnetic resonance imaging
topic magnetic resonance imaging
transperineal biopsy
prostate cancer
PI-RADS
target biopsy
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1142022/full
work_keys_str_mv AT taeilnoh diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging
AT jisungshim diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging
AT seokhokang diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging
AT juncheon diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging
AT sunggukang diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging